HR 1060
119th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Prescription drugs
Supply chain
Modern Authentication of Pharmaceuticals Act of 2025
Introduced: February 6, 2025
Introduced by:
Davis, Donald G.
Democratic
· North Carolina
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 6, 2025
Referred to the House Committee on Energy and Commerce.
Feb 6, 2025
Introduced in House
Feb 6, 2025
Sponsor introductory remarks on measure. (CR H519)
Plain-English summary
Modern Authentication of Pharmaceuticals Act of 2025
This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.
The bill applies to products manufactured beginning five years after the bill's enactment.
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1